Literature DB >> 32420547

Left Ventricular Extracellular Volume Expansion Is Not Associated with Atrial Fibrillation or Atrial Fibrillation-mediated Left Ventricular Systolic Dysfunction.

Suvai Gunasekaran1, Daniel C Lee1, Bradley P Knight1, Lexiaozi Fan1, Jeremy D Collins1, Kelvin Chow1, James C Carr1, Rod Passman1, Daniel Kim1.   

Abstract

PURPOSE: To determine whether left ventricular (LV) extracellular volume (ECV) expansion is associated with atrial fibrillation (AF) or AF-mediated LV systolic dysfunction (LVSD) while minimizing the influence of biologic and imaging methodologic confounders.
MATERIALS AND METHODS: This study examined the prevalence of LV ECV expansion in 137 patients with AF (mean age, 62 years ± 11 [standard deviation]; 92 male patients and 45 female patients; 83 paroxysmal and 54 persistent) who underwent preablation cardiovascular MRI. Biologic confounders were minimized by measuring the ECV fraction and excluding patients with severe LV hypertrophy, defined as wall thickness greater than 1.5 cm. Imaging confounders were minimized by using an arrhythmia-insensitive-rapid (AIR) cardiac T1 mapping pulse sequence. Other cardiac functional parameters, including LV ejection fraction (LVEF) and left atrial end-diastolic volume indexed to body surface area, were assessed using cine cardiovascular MRI. A substudy was conducted in 32 patients with no AF (mean age, 54 years ± 16) in sinus rhythm to establish control values and convert these values between the AIR sequence and literature-based modified Look-Locker inversion recovery (MOLLI) values.
RESULTS: The mean ECV was not significantly different (P > .05) between patients with AF with a normal LVEF (24.5% ± 2.8; n = 107), patients with AF with LVSD (24.5% ± 2.5; n = 30), and patients with no AF (24.4% ± 3.8; n = 32), but there was a significant interaction between ECV and CHA2DS2-VASc score (P = .045). Compared with the literature data obtained from healthy control patients scanned using MOLLI, 99.3% of patients with AF had ECV below the fibrosis cutoff point (32.8% when converted from MOLLI T1 mapping to AIR T1 mapping), including a subset of patients with AF (n = 28) with low CHA2DS2-VASc score (0/1 for men/women).
CONCLUSION: Study results suggest that an LV ECV expansion is not associated with AF or AF-mediated LVSD. Supplemental material is available for this article. © RSNA, 2020See also the commentary by Stillman in this issue. 2020 by the Radiological Society of North America, Inc.

Entities:  

Year:  2020        PMID: 32420547      PMCID: PMC7208181          DOI: 10.1148/ryct.2020190096

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  34 in total

Review 1.  Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle.

Authors:  Yong-Mei Cha; Margaret M Redfield; Win-Kuang Shen; Bernard J Gersh
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

Review 2.  Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.

Authors:  Elad Anter; Mariell Jessup; David J Callans
Journal:  Circulation       Date:  2009-05-12       Impact factor: 29.690

3.  Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping.

Authors:  Kelvin Chow; Jacqueline A Flewitt; Jordin D Green; Joseph J Pagano; Matthias G Friedrich; Richard B Thompson
Journal:  Magn Reson Med       Date:  2013-07-23       Impact factor: 4.668

4.  Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.

Authors:  Susana Ravassa; Gabriel Ballesteros; Begoña López; Pablo Ramos; Jean Bragard; Arantxa González; María U Moreno; Ramón Querejeta; Enrique Vives; Ignacio García-Bolao; Javier Díez
Journal:  J Am Coll Cardiol       Date:  2019-04-02       Impact factor: 24.094

5.  Atrial fibrillation and diffuse left ventricular fibrosis, a causal association?

Authors:  Henry R Halperin; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

Review 6.  Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics.

Authors:  Erik B Schelbert; Hani N Sabbah; Javed Butler; Mihai Gheorghiade
Journal:  Circ Cardiovasc Imaging       Date:  2017-06       Impact factor: 7.792

7.  Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.

Authors:  Sandeep Prabhu; Andrew J Taylor; Ben T Costello; David M Kaye; Alex J A McLellan; Aleksandr Voskoboinik; Hariharan Sugumar; Siobhan M Lockwood; Michael B Stokes; Bhupesh Pathik; Chrishan J Nalliah; Geoff R Wong; Sonia M Azzopardi; Sarah J Gutman; Geoffrey Lee; Jamie Layland; Justin A Mariani; Liang-Han Ling; Jonathan M Kalman; Peter M Kistler
Journal:  J Am Coll Cardiol       Date:  2017-08-27       Impact factor: 24.094

8.  Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence.

Authors:  Michelle Fitts; Elodie Breton; Eugene G Kholmovski; Derek J Dosdall; Sathya Vijayakumar; Kyung P Hong; Ravi Ranjan; Nassir F Marrouche; Leon Axel; Daniel Kim
Journal:  Magn Reson Med       Date:  2012-12-27       Impact factor: 4.668

Review 9.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

Authors:  James C Moon; Daniel R Messroghli; Peter Kellman; Stefan K Piechnik; Matthew D Robson; Martin Ugander; Peter D Gatehouse; Andrew E Arai; Matthias G Friedrich; Stefan Neubauer; Jeanette Schulz-Menger; Erik B Schelbert
Journal:  J Cardiovasc Magn Reson       Date:  2013-10-14       Impact factor: 5.364

10.  Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation.

Authors:  Lei Zhao; Songnan Li; Xiaohai Ma; Andreas Greiser; Tianjing Zhang; Jing An; Rong Bai; Jianzeng Dong; Zhanming Fan
Journal:  J Cardiovasc Magn Reson       Date:  2016-03-15       Impact factor: 5.364

View more
  2 in total

1.  Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.

Authors:  Mai Azuma; Shingo Kato; Ryusuke Sekii; Sho Kodama; Kei Kinoshita; Keisuke Suzurikawa; Minako Kagimoto; Naoki Nakayama; Kohei Iguchi; Kazuki Fukui; Tae Iwasawa; Daisuke Utsunomiya; Kazuo Kimura; Kouichi Tamura
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-16       Impact factor: 2.357

2.  Chewing the Fat on Atrial Fibrillation.

Authors:  Arthur E Stillman
Journal:  Radiol Cardiothorac Imaging       Date:  2020-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.